November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant

October 31, 2024

Semaglutide Shows Dual Benefit in Knee OA

In this 68-week trial, semaglutide not only achieved 13.7% weight reduction but also decreased NSAID use and improved walking distance by 42.6 meters compared to placebo in patients with knee osteoarthritis, suggesting potential benefits beyond weight loss.

Conexiant

October 30, 2024

Five Medical Societies Unite on GLP-1 Guidelines

Leading medical societies released unified perioperative guidance that challenges the practice of universal GLP-1RA discontinuation, instead advocating for individualized risk assessment and shared decision-making to prevent treatment disruption where safely possible.

Conexiant

October 29, 2024

Study: Parent Physicians Face $2M Pay Gap

Parent physicians face stark earning divides: mothers' pay drops with each child while fathers see raises, creating $2M career gap.

Conexiant

October 25, 2024

PCPs Struggle Most with Fecal Incontinence Care

Survey reveals steep experience gap: PCPs with 1-10 years of practice showed 4.41 times higher odds of discomfort managing pelvic organ prolapse compared to veterans with 20+ years, highlighting critical need for early-career training in women's health.

Conexiant

May 22, 2024

Study Links Gut Microbiome to Social Behavior

A new study reveals that changes in the gut microbiome can significantly impact social decision-making and behavior.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

April 26, 2024

Acid-Suppression Therapy Linked to Headache in Study

Recent data suggests a potential link between the use of acid-suppression therapies and an increased prevalence of migraines and severe headaches.

Conexiant

April 26, 2024

FDA Approves Dupilumab for Pediatric Patients With Eosinophilic Esophagitis

The U.S. Food and Drug Administration (FDA) approved dupilumab for the treatment of pediatric patients with eosinophilic esophagitis.

Conexiant